A new look at old problems: Ovarian function suppression in the real world
- PMID: 33508142
- DOI: 10.1002/cncr.33368
A new look at old problems: Ovarian function suppression in the real world
Keywords: adherence; adjuvant therapy; breast cancer; hormonal therapy; ovarian function suppression.
Comment on
-
Adherence to endocrine therapy including ovarian suppression: A large observational cohort study of US women with early breast cancer.Cancer. 2021 Apr 15;127(8):1220-1227. doi: 10.1002/cncr.33367. Epub 2021 Jan 28. Cancer. 2021. PMID: 33508140
References
-
- Park JH, Anderson WF, Gail MH. Improvements in US breast cancer survival and proportion explained by tumor size and estrogen-receptor status. J Clin Oncol. 2015;33:2870-2876.
-
- Narod SA, Iqbal J, Miller AB. Why have breast cancer mortality rates declined? J Cancer Policy. 2015;5:8-17.
-
- Partridge AH, Hughes ME, Warner ET, et al. Subtype-dependent relationship between young age at diagnosis and breast cancer survival. J Clin Oncol. 2016;34:3308-3314.
-
- Thomas A, Rhoads A, Pinkerton E, et al. Incidence and survival among young women with stage I-III breast cancer: SEER 2000-2015. JNCI Cancer Spectr. 2019;3:pkz040.
-
- Cai S, Zuo W, Lu X, et al. The prognostic impact of age at diagnosis upon breast cancer of different immunohistochemical subtypes: a Surveillance, Epidemiology, and End Results (SEER) population-based analysis. Front Oncol. 2020;10:1729.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources